Related Experiment Video
Updated: Feb 11, 2026

Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies
Published on: June 20, 2015
Combination Immunotherapy Approaches for Pancreatic Cancer Treatment
Xianliang Cheng1, Gang Zhao2, Yunqi Zhao1
1School of Pharmaceutical Sciences & Yunnan Provincial Key Laboratory of Pharmacology for Natural Products, Kunming Medical University, Kunming, Yunnan, China.
Abstract:
Pancreatic ductal adenocarcinoma is a lethal malignant disease with a very low medium survival. Currently, metastatic pancreatic cancer poorly responds to conventional treatments and exhibits an acute resistance to most chemotherapy. Few approaches have been shown to be effective for metastatic pancreatic cancer treatment. Novel therapeutic approaches to treat patients with pancreatic adenocarcinoma are in great demand. Last decades, immunotherapies have been evaluated in clinical trials and received great success in many types of cancers. However, it has very limited success in treating pancreatic cancer. As pancreatic cancer poorly responds to many single immunotherapeutic agents, combination immunotherapy was introduced to improve efficacy. The combination therapies hold great promise for enhancing immune responses to achieve better therapeutic effects. This review summarizes the existing and potential combination immunotherapies for the treatment of pancreatic cancer.
Insights
Pancreatic cancer is a deadly disease with limited treatment options. Combination immunotherapy shows promise for improving treatment efficacy by enhancing immune responses against pancreatic adenocarcinoma.
Area of Science:
- Oncology
- Immunotherapy
- Cancer Research
Background:
- Pancreatic ductal adenocarcinoma (PDAC) is a highly lethal malignancy with poor patient survival rates.
- Metastatic pancreatic cancer demonstrates significant resistance to conventional chemotherapy and existing treatments.
- There is a critical unmet need for novel and effective therapeutic strategies for pancreatic adenocarcinoma.
Purpose of the Study:
- To review current and emerging combination immunotherapy approaches for pancreatic cancer.
- To highlight the potential of combination therapies in overcoming treatment resistance in pancreatic adenocarcinoma.
- To provide insights into enhancing anti-tumor immune responses for improved therapeutic outcomes.
Main Methods:
- Literature review of clinical trials and preclinical studies on pancreatic cancer immunotherapy.
- Analysis of the efficacy and challenges of single-agent immunotherapies in pancreatic cancer.
- Synthesis of data on combination immunotherapy strategies in pancreatic adenocarcinoma.
Main Results:
- Single-agent immunotherapies have shown limited success in treating pancreatic cancer.
- Combination immunotherapy strategies are being explored to enhance efficacy.
- Combination therapies aim to potentiate immune responses against pancreatic adenocarcinoma.
Conclusions:
- Combination immunotherapy represents a promising avenue for improving treatment outcomes in pancreatic cancer.
- Further research and clinical trials are needed to optimize combination immunotherapy regimens.
- Developing effective combination immunotherapies is crucial for advancing pancreatic adenocarcinoma treatment.
Related Concept Videos
Treatment Resistant Cancers
Tumor Immunotherapy
Frustration and Conflict: Approach-Approach, Approach-Avoidance
One common type of conflict is the Approach–Approach Conflict. In this case, a person faces two desirable...
Pancreatic Juice and Secretion
When acidic chyme from the stomach enters the duodenum, it triggers the release of secretin, a hormone that prompts pancreatic juice secretion. After a fatty meal, cholecystokinin, another hormone, stimulates gallbladder contraction and enhances enzyme-rich...
Acute Pancreatitis I: Introduction
Acute pancreatitis is characterized by rapid inflammation of the pancreas, often caused by factors like gallstone blockage or excessive alcohol consumption. Chronic pancreatitis, on the other hand, is a slow, progressive inflammation that may result from long-term alcohol abuse, obstructions in the pancreatic duct, or genetic factors.
The causes of acute pancreatitis include:
Chronic Pancreatitis I: Introduction
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...

